Spots Global Cancer Trial Database for hdr brachytherapy
Every month we try and update this database with for hdr brachytherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine | |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine | |
| HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer | NCT03424694 | Prostate Cancer | HDR brachythera... | 18 Years - 85 Years | CR-CSSS Champlain-Charles-Le Moyne | |
| High-Dose-Rate Brachytherapy | NCT00913939 | Patients With P... | MRI Guided Need... MRI Guided Need... | 18 Years - | University Health Network, Toronto | |
| Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy | NCT03312972 | Locally Recurre... | HDR Brachythera... | 18 Years - | Loyola University | |
| HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer | NCT03424694 | Prostate Cancer | HDR brachythera... | 18 Years - 85 Years | CR-CSSS Champlain-Charles-Le Moyne | |
| High-Dose-Rate Brachytherapy | NCT00913939 | Patients With P... | MRI Guided Need... MRI Guided Need... | 18 Years - | University Health Network, Toronto | |
| Pilot Study of a Catheter-based Ultrasound Hyperthermia System | NCT00911079 | Cervical Cancer Prostate Cancer | Hyperthermia HDR brachythera... | 18 Years - | University of California, San Francisco | |
| Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer | NCT03862170 | Prostate Cancer | Ciprofloxacin Cefazolin | 18 Years - 85 Years | CR-CSSS Champlain-Charles-Le Moyne | |
| EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer | NCT04465500 | Prostate Cancer Prostate Adenoc... | External Beam R... HDR Brachythera... Androgen Depriv... | 18 Years - | University of Virginia | |
| Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer | NCT02560181 | Prostate Cancer... | HDR brachythera... | - | Sunnybrook Health Sciences Centre | |
| A Study of Patients Receiving High-Dose Rate Brachytherapy | NCT00924027 | Cervical Cancer Endometrial Can... Esophageal Canc... Prostate Cancer Biliary Cancer | HDR Brachythera... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung | NCT03051802 | Esophagus Cance... Lung Cancer | Navigated Endos... | 18 Years - | University Health Network, Toronto | |
| Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy | NCT03312972 | Locally Recurre... | HDR Brachythera... | 18 Years - | Loyola University | |
| Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment | NCT02618161 | Prostate Cancer | HDR Brachythera... External beam R... | 18 Years - | Mid and South Essex NHS Foundation Trust | |
| Hypofractionated Whole Pelvic Radiotherapy of the Prostate | NCT02546427 | Prostate Cancer | Helical TomoThe... CyberKnife SBRT Permanent Prost... HDR brachythera... | 18 Years - | University of California, San Francisco | |
| Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial | NCT02283346 | Prostatic Neopl... | HDR brachythera... | 18 Years - 90 Years | AC Camargo Cancer Center | |
| High-Dose-Rate Brachytherapy | NCT00913939 | Patients With P... | MRI Guided Need... MRI Guided Need... | 18 Years - | University Health Network, Toronto | |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
